Clinically assisted hydration in advanced cancer.

Andrew Davies

Journal: Current opinion in supportive and palliative care 2025;19(3):188-191

PMID: 40408332

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

PURPOSE OF REVIEW

The initiation/continuation of clinically assisted hydration (CAH) in patients with advanced cancer, especially those in the last days of life, remains highly controversial. The purpose of this article is to review recent developments relating to this medical intervention.

RECENT FINDINGS

The volume of 'new' literature identified was relatively low, and the quality of this evidence was also relatively low. Furthermore, there are questions over the adequacy of fluid therapy administered in many of these/previous clinical studies.

SUMMARY

Currently, there is little evidence to guide clinical practice, although the Multinational Association of Supportive Care in Cancer have produced new expert consensus guidance to support decision making in patients with advanced cancer.

Address: Professor of Palliative Medicine, Trinity College Dublin, University College Dublin, Our Lady's Hospice & Care Services, Dublin, Ireland.

DOI: 10.1097/SPC.0000000000000760

Link outs

Free resources

Medical:

https://medlineplus.gov/palliativecare.html

Research Materials:

https://antibodies.cancer.gov/detail/CPTC-BRIP1-5

Subscription / membership required

Full Text Sources:

MeSH Terms: Humans, Neoplasms, Fluid Therapy, Palliative Care, Dehydration, Terminal Care